3696:HKG
Insilico Medicine Cayman TopCo
HK$37.98
arrow_downward
-1.96%(-0.76) 1D
Jun 5, 4:09:10 PM GMT+8 · HKD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 3696...
Open
HK$39.08
High
HK$41.08
Low
HK$37.72
Mkt. cap
22.05B
Avg. vol.
3.50M
Volume
4.68M
52-wk high
HK$80.90
52-wk low
HK$29.98
EPS
-HK$4.95
Shares outstanding
557.42M
No. of employees
317
Open
HK$39.08
High
HK$41.08
Low
HK$37.72
Mkt. cap
22.05B
Avg. vol.
3.50M
Volume
4.68M
52-wk high
HK$80.90
52-wk low
HK$29.98
EPS
-HK$4.95
Shares outstanding
557.42M
No. of employees
317
Analyst outlook
Analyst Ratings
Based on 3 analysts giving stock ratings to 3696 in the past 3 months
Strong Buy
Buy
3
Hold
0
Sell
0
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for 3696 in the last 3 months.
Highest
Current HK$37.98
HK$77.97 (+105.29%)
Average
HK$77.26 (+103.42%)
Lowest
HK$76.80 (+102.21%)
News stories
From sources across the web
Profile
Insilico Medicine is a biotechnology company headquartered in Boston, Massachusetts, with additional facilities in Pak Shek Kok, Hong Kong in Hong Kong Science Park near the Chinese University of Hong Kong, and in New York, at The Cure by Deerfield. The company combines genomics, big data analysis, and deep learning for in silico drug discovery. Wikipedia
About Insilico Medicine Cayman TopCo
CEOFeng Ren | Alex Zhavoronkov
Employees317
Founded2014
Headquarters-
SectorHealth care
Websiteinsilico.com
AI content may include mistakes. Learn more